PDK1 and cancer: It is noteworthy that a recent study by Frisch et al. took a pharmacological approach with dichloroacetate (DCA) to temporarily inhibit PDK1 in vitro, which improved T cell efficacy against cancer accompanied by increased stemness characteristics and survival of T cells (76).